NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Tuesday, March 24, 2009  
Patient Stories In Modern Medicine: Medical Symposium Highlights Importance Of Case Reports
Patient Stories In Modern Medicine: Medical Symposium Highlights Importance Of Case Reports
The event, 'Celebrating case reports, the stories in health care', will be held at the Royal College of Physicians in London on 15 May this year, and will bring together leading doctors from many medical specialties. The meeting will be chaired by the Editors of Cases Network's journals - Richard Smith (the former editor of the BMJ) and Professor Michael Kidd (Flinders University, Australia).
Source: www.medicalnewstoday.com

Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Boehringer Ingelheim announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
Source: www.medicalnewstoday.com

Vertigo Linked To Osteoporosis
People who have osteoporosis are more likely to also have vertigo, according to a study published in the March 24, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved 209 people with benign positional vertigo with no known cause such as head trauma or ear surgery. Vertigo is an inner ear disorder that is a common cause of dizziness.
Source: www.medicalnewstoday.com

Bumrungrad Named Best Small Cap Company in 2008

Bumrungrad International hospital was named Thailand's "Best Small Cap Company" in the December 2008/January 2009 issue of Asiamoney, a leading financial magazine in the Asia-Pacific region. The award is the result of Asiamoney's annual poll of fund managers and analysts to recognize the best-managed small, medium, and large cap corporations across the region. (PRWeb Mar 24, 2009)

Read the full story at http://www.prweb.com/releases/Bumrungrad/Best_Small_Cap_Firm2008/prweb2255974.htm


Source: www.prweb.com

ImVisioN Therapeutics Reports Positive Phase I Clinical Results For Treatment Of Cat Dander Allergy
ImVisioN Therapeutics AG, a biopharmaceutical company pioneering intralymphatic immunotherapy (ILIT™), today announced that it has obtained positive Phase I clinical results for its lead product, IVN201 (Cat-MAT), an immunotherapeutic product for the treatment of cat dander allergy. The study was conducted from August 2008 to March 2009 in a total of 20 patients with allergy to cat dander.
Source: www.medicalnewstoday.com

Watchful Waiting Versus Radical Prostatectomy: SPCG-4 Trial Update
In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. At the 24th Annual EAU Congress in Stockholm, Sweden the results after 3 more years of follow-up were reported by Professor Lars Holmberg from Uppsala, Sweden.
Source: www.medicalnewstoday.com

Former House Democratic Leader Richard A. Gephardt To Join MMR Initiative To Promote Immediate Use Of Personal Health Records
MMR Information Systems, Inc. (OTC Bulletin Board: FVRL), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled Personal Health Records ("PHRs") (http://www.mymedicalrecords.com) and electronic safe deposit box storage solutions (http://www.myesafedepositbox.
Source: www.medicalnewstoday.com

Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.